Compare & Contrast Graphic Organizer

Sinovac Vaccine is a Covid AstraZeneca Vaccine is a vaccine from the

vaccine which was founded in Oxford-AstraZeneca collaboration, which is a
2001 in Beijing by our CEO, Mr. vaccine capable of triggering an immune
Weidong Yin. response against diseases such as COVID-19.

Different Features Similar Features Different Features

The best time to The COVID-19 The second dose of
receive the second vaccine is given by AstraZeneca-
dose is 28 days after intramuscular produced COVID-
injection in the upper
the first injection 19 vaccine was
left arm.
received 12 weeks
Platform by
Vaccination is not after the first dose.
inactivated virus given to Covid-19
survivors (has been Platform by viral-
The number of doses
declared cured for at vector (non
of vaccine 2 is 0.5
least 3 months), replicating)
per dose.
pregnant women,
breastfeeding, aged < The number of doses
18 years, and some 1-2 is 0.5 per dose.
morbid conditions.

Conclusion:
COVID-19 vaccination aims to reduce the transmission/transmission of COVID-19,
reduce morbidity and mortality due to COVID-19, achieve herd immunity, and
protect the community from COVID-19 to remain socially and economically
productive.
The provision of COVID-19 vaccination, accompanied by the implementation of strict
health protocols, is an acceleration effort in the context of dealing with the pandemic
COVID-19 vaccination activities include the stages of planning, implementation as
well as monitoring and evaluation, where all of these stages will be supported by an
integrated information system.
 Comparation of Covid -19 Vaccines (Sinovac and AstraZeneca Vaccines)

Sinovac Vaccine is a Covid vaccine that was founded in 2001 in Beijing by our
CEO, Mr. Weidong Yin. Meanwhile, AstraZeneca Vaccine is a vaccine from the Oxford-
AstraZeneca collaboration, which is a vaccine capable of triggering an immune response
against diseases such as COVID-19.
Sinovac vaccine exclusivity is the best time to receive the second dose is 28 days
after the first injection, platform by inactivated virus and the number of doses of vaccine 2
is 0.5 per dose.
Whereas for the second dose of the AstraZeneca-produced COVID-19 vaccine was
received 12 weeks after the first dose, platform by viral-vector (non replicating) and the
number of doses 1-2 is 0.5 per dose.
Both vaccines have something in common, that is the purpose of the COVID-19
vaccine is given by intramuscular injection in the upper left arm, and vaccination is not
given to Covid-19 survivors (has been declared cured for at least 3 months), pregnant
women, breastfeeding, aged < 18 years, and some morbid conditions.
Thus, COVID-19 vaccination aims to reduce the transmission/transmission of
COVID-19, reduce morbidity and mortality due to COVID-19, achieve herd immunity,
and protect the community from COVID-19 to remain socially and economically
productive. The provision of COVID-19 vaccination, accompanied by the implementation
of strict health protocols, is an acceleration effort in the context of dealing with the
pandemic COVID-19 vaccination activities include the stages of planning, implementation
as well as monitoring and evaluation, where all of these stages will be supported by an
integrated information system.
 REFERENSES
Iskandar, Haris et all. 2021. Pengendalian COVID-19 dengan 3M, 3T, Vaksinasi, Disiplin,
Kompak, dan Konsisten Buku 2. Jakarta: Satuan Tugas Penanganan COVID-19.
Nadia, Siti. 2021. Kebijakan Pelaksanaan Vaksinasi Covid-19. Direktorat Jenderal
Pencegahan dan Pengendalian Penyakit Kementerian Kesehatan.
Nasir, N M. 2021. Kebijakan Vaksinasi COVID-19: Pendekatan Pemodelan Matematika
Dinamis Pada Efektivitas Dan Dampak Vaksin Di Indonesia. UBJ: Jurnal
ABDIMAS (Pengabdian kepada Masyarakat).